10x Genomics (TXG) Other Non-Current Assets (2018 - 2026)

10x Genomics' Other Non-Current Assets history runs 9 years deep, the most recent figure standing at $2.6 million for Q1 2026.

• In Q1 2026, Other Non-Current Assets rose 14.29% year-over-year to $2.6 million; the TTM figure through Mar 2026 stood at $2.6 million (up 14.29% YoY), while the FY2025 annual figure was $2.9 million, down 29.45% from the prior year.
• Other Non-Current Assets came in at $2.6 million for Q1 2026 at 10x Genomics, down from $2.9 million in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $61.0 million in Q4 2023 to a low of $1.9 million in Q3 2025.
• A 5-year average of $7.2 million and a median of $3.1 million in 2022 frame the typical range for Other Non-Current Assets.
• On a YoY basis, Other Non-Current Assets climbed as much as 83.36% in 2024 and fell as far as 93.23% in 2024.
• 10x Genomics' Other Non-Current Assets stood at $2.9 million in 2022, then soared by 2002.03% to $61.0 million in 2023, then sank by 93.23% to $4.1 million in 2024, then decreased by 29.45% to $2.9 million in 2025, then declined by 9.92% to $2.6 million in 2026.
• According to Business Quant data, Other Non-Current Assets over the past three periods registered $2.6 million, $2.9 million, and $1.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison